Sagewood Asset Management’s MaxCyte MXCT Stock Holding History

Sagewood Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,598	Closed	-$21.1K	–	367
2025 Q4	$21.1K	Buy	+13,598	New	+$21.7K	0.01%	256

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Sagewood Asset Management's MXCT Position: Q1 2026 in Review

Sagewood Asset Management sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 13,598 shares — an estimated $21.1K sold.

Sagewood Asset Management first reported a position in MXCT in Q4 2025 and held it in 1 quarter. The position peaked at $21.1K in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Sagewood Asset Management reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
Sagewood Asset Management sold 13,598 MaxCyte shares in Q1 2026, an estimated $21.1K.
Sagewood Asset Management first reported a position in MaxCyte in Q4 2025 and held it in 1 quarter.
Sagewood Asset Management's MaxCyte position peaked at $21.1K in Q4 2025.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Sagewood Asset Management's 13F filing for Q1 2026, filed 13 May 2026.